209 related articles for article (PubMed ID: 15249786)
21. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
[TBL] [Abstract][Full Text] [Related]
22. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
[TBL] [Abstract][Full Text] [Related]
23. Scalp psoriasis: a review of current topical treatment options.
Papp K; Berth-Jones J; Kragballe K; Wozel G; de la Brassinne M
J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1151-60. PubMed ID: 17894698
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
Kragballe K; Hoffmann V; Ortonne JP; Tan J; Nordin P; Segaert S
Br J Dermatol; 2009 Jul; 161(1):159-66. PubMed ID: 19416259
[TBL] [Abstract][Full Text] [Related]
25. Treatment options for psoriasis.
Dunn ML; Cockerline EB; Rice MR
Am J Nurs; 1988 Aug; 88(8):1081-7. PubMed ID: 3400747
[No Abstract] [Full Text] [Related]
26. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
Buckley C; Hoffmann V; Shapiro J; Saari S; Cambazard F; Milsgaard M
Dermatology; 2008; 217(2):107-13. PubMed ID: 18463448
[TBL] [Abstract][Full Text] [Related]
27. Calcitriol 3 microg/g ointment: an effective and safe addition to the armamentarium in topical psoriasis therapy.
Abramovits W
J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s17-22. PubMed ID: 19702032
[TBL] [Abstract][Full Text] [Related]
28. Different treatment outcomes with different formulations of clobetasol propionate 0.05% for the treatment of plaque psoriasis.
Mraz S; Leonardi C; Colón LE; Johnson LA
J Dermatolog Treat; 2008; 19(6):354-9. PubMed ID: 18923991
[TBL] [Abstract][Full Text] [Related]
29. Calcipotriol cream: a review of its use in the management of psoriasis.
Segaert S; Duvold LB
J Dermatolog Treat; 2006; 17(6):327-37. PubMed ID: 17853305
[TBL] [Abstract][Full Text] [Related]
30. Current effective topical therapies in the management of psoriasis.
Kurian A; Barankin B
Skin Therapy Lett; 2011 Jan; 16(1):4-7. PubMed ID: 21293834
[TBL] [Abstract][Full Text] [Related]
31. Scalp psoriasis: European consensus on grading and treatment algorithm.
Ortonne J; Chimenti S; Luger T; Puig L; Reid F; Trüeb RM
J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1435-44. PubMed ID: 19614856
[TBL] [Abstract][Full Text] [Related]
32. Topical preparations for the treatment of psoriasis: results of a retrospective study over 15 years.
Zampetti A; Barone A; Antuzzi D; Amerio P; Tulli A; Feliciani C; Amerio P
J Dermatolog Treat; 2008; 19(3):134-40. PubMed ID: 18569269
[TBL] [Abstract][Full Text] [Related]
33. A lipohydroxyacid-containing shampoo improves scalp condition and quality of life in patients with seborrheic dermatitis and light-to-moderate scalp psoriasis.
Seité S; Paries J; Reygagne P; Hamidou Z; Jouanique C; Perez-Pala G; Rougier A
J Cosmet Dermatol; 2009 Jun; 8(2):108-13. PubMed ID: 19527334
[TBL] [Abstract][Full Text] [Related]
34. Comparison of tazarotene 0.1% gel plus petrolatum once daily versus calcipotriol 0.005% ointment twice daily in the treatment of plaque psoriasis.
Tzung TY; Wu JC; Hsu NJ; Chen YH; Ger LP
Acta Derm Venereol; 2005; 85(3):236-9. PubMed ID: 16040409
[TBL] [Abstract][Full Text] [Related]
35. Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents.
Kimball AB; Gold MH; Zib B; Davis MW;
J Am Acad Dermatol; 2008 Sep; 59(3):448-54, 454.e1. PubMed ID: 18539358
[TBL] [Abstract][Full Text] [Related]
36. Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol ointment.
Sánchez Regaña M; Márquez Balbás G; Umbert Millet P
J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):963-9. PubMed ID: 18410337
[TBL] [Abstract][Full Text] [Related]
37. Acrodermatitis continua of Hallopeau on toes successfully treated with a two-compound product containing calcipotriol and betamethasone dipropionate.
Sotiriadis D; Patsatsi A; Sotiriou E; Sotiriou E; Papagaryfallou I; Chrysomallis F
J Dermatolog Treat; 2007; 18(5):315-8. PubMed ID: 17852633
[TBL] [Abstract][Full Text] [Related]
38. Biopsy proven morphea treated with tacalcitol ointment: case report.
Ascari-Raccagni A; Dondas A; Dubini A; Righini MG; Trevisan G
Acta Dermatovenerol Croat; 2010; 18(4):248-51. PubMed ID: 21251440
[TBL] [Abstract][Full Text] [Related]
39. Dermoscopic assessment of long-term topical therapies with potent steroids in chronic psoriasis.
Vázquez-López F; Marghoob AA
J Am Acad Dermatol; 2004 Nov; 51(5):811-3. PubMed ID: 15523365
[TBL] [Abstract][Full Text] [Related]
40. Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis.
Lowe N; Feldman SR; Sherer D; Weiss J; Shavin JS; Lin YL; Foley V; Soto P
J Dermatolog Treat; 2005 Aug; 16(3):158-64. PubMed ID: 16096182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
